CALR mutastion analysis is a profound new solution in the diagnosis of myloproliferative neoplasms.
NeoGenomics BioPharma Services is a world class, custom, scientific solutions to innovate and execute your oncology drug development strategies.
NeoSITE B.E.: Barrett's Esophagus FISH Panel provides unique insight into the presense or potential for malignancy in Barrett's lesions.
Let us hep you build your case: Our broad portfolio of tech-only products will help your pathology group compete against national reference laboratories.

NeoGenomics Video

 


Upcoming Events

2014 Dermpedia Comprehensive Review of Cutaneous Hematopathology and Dermatopathology

Date: April 10 - April 12, 2014
Location: Scottsdale, AZ

Petition Congress and CMS to retract proposed rule for payment revisions.

Hot Topic

 

Learn More about CALR testing so you can make the right decision for your patients.

 
 
 

Covance and NeoGenomics Enter into Exclusive Alliance

Click here to learn more about NeoGenomics Clinical Trials Services and read full press release.

 

NeoGenomics open positions 

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List iconSign Up for Free Email Updates
 

Recent Investor News:

Recent NCCI Edits

Click Here to Access the latest changes in billing issued by the National Correct Coding Initiative (NCCI).

Click Here for the ACLA Comment Letter to CMS Regarding Recent NCCI FISH Edits, dated 3/19/14.